Eurobio Scientific Logo

Eurobio Scientific

Develops & distributes specialty IVD tests for oncology, transplant & infectious diseases.

ALERS | PA

Overview

Corporate Details

ISIN(s):
FR0004054435 (+2 more)
LEI:
969500IQEUEH806GE257
Country:
France
Address:
7 AVENUE DE SCANDINAVIE, 91940 LES ULIS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Eurobio Scientific is an integrated specialty diagnostics company focused on developing, manufacturing, and distributing in-vitro diagnostic (IVD) tests and life sciences products for clinical use. The company's core areas of expertise are transplantation, infectious diseases, and oncology. Its portfolio includes a range of molecular diagnostics technologies, such as prognostic genomic tests for cancer, reagents and software for transplant matching, and genetic tests for various illnesses. Eurobio Scientific serves laboratories and healthcare providers, offering both its own proprietary solutions, which constitute a significant portion of its revenue, and products from partner companies through its distribution network.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-24 17:40
Earnings Release
Eurobio Scientific : résultat du 1er semestre 2025
French 270.5 KB
2025-09-24 17:40
Earnings Release
EUROBIO SCIENTIFIC: RESULTS FOR THE FIRST SEMESTER OF FISCAL YEAR 2025
English 276.5 KB
2025-07-01 17:45
M&A Activity
Eurobio Scientific finalise l'acquisition de l'unité Sciences de la vie de Vod…
French 177.0 KB
2025-07-01 17:45
M&A Activity
Eurobio Scientific completes the acquisition of Life Science unit of Voden Med…
English 173.7 KB
2025-06-17 16:59
Major Shareholding Notification
Franchissement de seuils
French 116.1 KB
2025-05-19 19:16
Major Shareholding Notification
Eurobio Scientific : EB Development franchit à la hausse le seuil de 90%
French 135.1 KB
2025-05-19 19:16
Major Shareholding Notification
Eurobio Scientific: EB Development rises above 90% threshold
English 134.8 KB
2025-04-29 21:00
Report Publication Announcement
Eurobio Scientific: MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2024
French 610.9 KB
2025-04-28 17:46
Earnings Release
Eurobio Scientific : RESULTAT ANNUEL 2024 - Croissance du cœur d’activité et dé…
French 216.3 KB
2025-04-28 17:46
Earnings Release
Eurobio Scientific: 2024 annual results
English 231.2 KB
2025-03-12 17:35
M&A Activity
EUROBIO SCIENTIFIC ÉTEND SA PRÉSENCE EN ITALIE
French 131.2 KB
2025-03-12 17:35
M&A Activity
EUROBIO SCIENTIFIC INCREASES ITS FOOTPRINT IN ITALY
English 133.7 KB
2025-03-04 20:03
Regulatory News Service
Eurobio Scientific : résiliation du contrat de liquidité
French 134.6 KB
2025-01-15 17:46
Report Publication Announcement
Eurobio Scientific : calendrier des publications financieres 2025
French 598.6 KB
2024-12-19 10:30
Declaration of Voting Results & Voting Rights Announcements
Eurobio Scientific : EB Development obtient une très large majorité du capital …
French 918.1 KB

Automate Your Workflow. Get a real-time feed of all Eurobio Scientific filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Eurobio Scientific via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-12-18 N/A Other Buy 1,000 15,180.00 EUR

Peer Companies

Company Country Ticker View
Lytix Biopharma AS Logo
Develops oncolytic peptide immunotherapies that kill cancer and stimulate an anti-tumor response.
Norway LYTIX
MaaT Pharma Logo
Developing gut microbiome therapies to improve survival for cancer patients.
France MAAT
Mabion S.A. Logo
Global CDMO providing end-to-end services for developing and manufacturing complex biologic drugs.
Poland MAB
Magle Chemoswed Holding AB Logo
A CDMO for pharma/med device firms, offering end-to-end development and specialized manufacturing.
Sweden MAGLE
Develops at-home diagnostic tests for the early detection of life-threatening cancers.
Germany N/A
Marinomed Biotech AG Logo
Develops virus-blocking products & immunology therapies via proprietary technology platforms.
Austria MARI
Matricelf Ltd. Logo
Develops personalized 3D neural implants from patient cells to treat spinal cord injuries.
Israel MTLF
Median Diagnostics Inc. Logo
Manufactures veterinary IVD kits & raw materials to diagnose infectious animal diseases.
South Korea 233250
MediciNova,Inc. Logo
Developing small-molecule drugs for neurology, respiratory, and liver diseases.
Japan 4875
Medicon Hellas S.A. Logo
Develops, makes, and sells IVD products, analytical systems & software for healthcare providers.
Greece MEDIC

Talk to a Data Expert

Have a question? We'll get back to you promptly.